These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 24991405)

  • 1. Chronic kidney disease and osteoporosis: evaluation and management.
    Miller PD
    Bonekey Rep; 2014; 3():542. PubMed ID: 24991405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic kidney disease and the skeleton.
    Miller PD
    Bone Res; 2014; 2():14044. PubMed ID: 26273531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnosis and treatment of osteoporosis in patients with chronic kidney disease : Joint guidelines of the Austrian Society for Bone and Mineral Research (ÖGKM), the Austrian Society of Physical and Rehabilitation Medicine (ÖGPMR) and the Austrian Society of Nephrology (ÖGN)].
    Cejka D; Wakolbinger-Habel R; Zitt E; Fahrleitner-Pammer A; Amrein K; Dimai HP; Muschitz C
    Wien Med Wochenschr; 2023 Oct; 173(13-14):299-318. PubMed ID: 36542221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoporosis in Patients with Chronic Kidney Diseases: A Systemic Review.
    Hsu CY; Chen LR; Chen KH
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32961953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoporosis and Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD): Back to Basics.
    Pazianas M; Miller PD
    Am J Kidney Dis; 2021 Oct; 78(4):582-589. PubMed ID: 33774081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The treatment of the patient presenting with chronic kidney disease (CKD) and fragility fractures].
    Giusti A; Fusaro M
    G Ital Nefrol; 2017 Dec; 34(Nov-Dec):. PubMed ID: 29207226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone biopsy: an ally in the management of fragility fractures in chronic kidney disease.
    Aguiar F; Meng C; Pereira L; Brito I; Frazão JM
    Acta Reumatol Port; 2018; 43(3):201-209. PubMed ID: 30414368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone disease in CKD: a focus on osteoporosis diagnosis and management.
    Miller PD
    Am J Kidney Dis; 2014 Aug; 64(2):290-304. PubMed ID: 24726630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoporosis, bone mineral density and CKD-MBD: treatment considerations.
    Bover J; Bailone L; López-Báez V; Benito S; Ciceri P; Galassi A; Cozzolino M
    J Nephrol; 2017 Oct; 30(5):677-687. PubMed ID: 28432640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current therapeutic approach of chronic kidney disease-mineral and bone disorder.
    Zaimi M; Grapsa E
    Ther Apher Dial; 2024 Oct; 28(5):671-689. PubMed ID: 38898685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and treatment of osteoporosis in chronic renal disease.
    Miller PD
    Semin Nephrol; 2009 Mar; 29(2):144-55. PubMed ID: 19371805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone Disease in Chronic Kidney Disease and Kidney Transplant.
    Bellorin-Font E; Rojas E; Martin KJ
    Nutrients; 2022 Dec; 15(1):. PubMed ID: 36615824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review and perspective on the assessment, management and prevention of fragility fractures in patients with osteoporosis and chronic kidney disease.
    Hampson G; Elder GJ; Cohen-Solal M; Abrahamsen B
    Endocrine; 2021 Sep; 73(3):509-529. PubMed ID: 33974225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoporosis, bone mineral density and CKD-MBD (II): Therapeutic implications.
    Bover J; Ureña-Torres P; Laiz Alonso AM; Torregrosa JV; Rodríguez-García M; Castro-Alonso C; Górriz JL; Benito S; López-Báez V; Lloret Cora MJ; Cigarrán S; DaSilva I; Sánchez-Bayá M; Mateu Escudero S; Guirado L; Cannata-Andía J
    Nefrologia (Engl Ed); 2019; 39(3):227-242. PubMed ID: 30797619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current Understanding of Mineral and Bone Disorders of Chronic Kidney Disease and the Scientific Grounds on the Use of Exogenous Parathyroid Hormone in Its Management.
    Pazianas M; Miller PD
    J Bone Metab; 2020 Feb; 27(1):1-13. PubMed ID: 32190604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of unfractionated heparin on renal osteodystrophy and vascular calcification in chronic kidney disease rats.
    Meng Y; Zhang H; Li Y; Li Q; Zuo L
    Bone; 2014 Jan; 58():168-76. PubMed ID: 24145307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current and Emerging Markers and Tools Used in the Diagnosis and Management of Chronic Kidney Disease-Mineral and Bone Disorder in Non-Dialysis Adult Patients.
    Fusaro M; Pereira L; Bover J
    J Clin Med; 2023 Sep; 12(19):. PubMed ID: 37834950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic kidney disease and fragility fracture.
    Kazama JJ
    Clin Exp Nephrol; 2017 Mar; 21(Suppl 1):46-52. PubMed ID: 28012057
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.